Obsessive-compulsive disorder (OCD) is a common illness which starts i
n young adulthood and persists into late life. OCD is associated with
dysregulation of the serotonin system and may also be related to the d
ysregulation of dopamine. When OCD starts in an elderly patient, eithe
r an organic or a neurological diagnosis should be considered. Clomipr
amine and serotonin reuptake inhibitors are the mainstay of treatment
for OCD. Choice of a particular agent should be based on the patient's
previous response and the adverse effect profile of the drug. Pharmac
okinetics should also be a consideration due to age-related changes in
hepatic and renal function leading to increased plasma concentrations
as well as prolonged elimination half-lives of these agents. Behaviou
ral therapy, in addition to pharmacological management, is essential t
o treat compulsions and to improve response.